With 7,000 medicines and vaccines in the global pipeline, the future of health looks exciting. The pharmaceutical industry is pioneering new treatments and new technologies that will change the face of modern medicine. Explore just some of those areas here.
The ABPI is at the heart of a health sector-wide effort to establish consensus on key Brexit issues. Click here for our view and for more information about how our sector is preparing for Brexit if there's 'no deal'.
Millions of people wouldn't be here today if it wasn't for life-changing science. And many more wouldn't be living the lives they do.
08 February 2019
A Europe-wide initiative to protect patients and public health from falsified or fake medicines goes live on Saturday 9 February 2019, making the medicines supply chain across Europe safer than ever before.
05 February 2019
As the UK prepares to leave the EU, the House of Lords is debating a Statutory Instrument which would weaken the UK’s IP framework and damage the country’s reputation as leader in life sciences.
30 January 2019
The UK must plug an increasing number of science skills gaps to maintain its world-leading position for medicines and vaccines research and development, says the ABPI.
24 January 2019
The Chancellor has announced a £100 million investment for research and technology.
12 February 2019
Preventing infections will help us get antimicrobial resistance (AMR) under control, according to a new plan from the UK Government.
11 February 2019
The Topol review of digital training needs for the NHS is published today. It says that cross-sector collaboration is vital - Andrew Croydon, Director of Skills and Education policy at the ABPI, agrees.